{"id":25147,"date":"2022-09-26T12:26:01","date_gmt":"2022-09-26T19:26:01","guid":{"rendered":"https:\/\/medicine.wsu.edu\/news\/?post_type=tribe_events&p=25147"},"modified":"2023-01-03T09:17:32","modified_gmt":"2023-01-03T17:17:32","slug":"bioethics-grand-rounds-2","status":"publish","type":"tribe_events","link":"https:\/\/medicine.wsu.edu\/news\/event\/bioethics-grand-rounds-2\/","title":{"rendered":"Bioethics Grand Rounds"},"content":{"rendered":"

Ethics, Informatics, and Artificial Intelligence in Medical Practice<\/h2>\n

November 9<\/strong><\/p>\n

Noon – 1:00 p.m.<\/p>\n

Bioethics Grand Rounds are sponsored by the Elson S. Floyd College of Medicine Certificate Program in Medical Ethics, offered in collaboration with the Kaiser Permanente Northern California Regional Ethics program.<\/p>\n

Register<\/a><\/h3>\n

About the speakers:<\/strong><\/p>\n

Yoav Schlesinger<\/strong> is an Architect of Ethical AI Practice in the Office of Ethical and Humane Use of Technology at Salesforce, where he helps the company embed and instantiate ethical production practices to maximize the societal benefits of AI. Prior to coming to Salesforce, Yoav was a founding member of the Tech and Society Solutions Lab at Omidyar Network, where he led the Responsible Computer Science Challenge and helped develop Ethical OS, a risk mitigation toolkit for product managers. Before that, he had a career as a leader and two-time founder of mission-driven, nonprofit organizations. He graduated from Stanford University with degrees in Religious Studies and Political Science and Honors in International Security Studies.<\/p>\n

Elizabeth Worthey<\/strong>, PhD, is an Endowed Associate Professor at the University of Alabama, Birmingham and the Director of the UAB School of Medicine Center for Computational Genomics and Data Science. She is also an Associate Director for the Hugh Kaul Precision Medicine Institute, Director of Bioinformatics for the O\u2019Neal Comprehensive Cancer Center, Director of Bioinformatics for the UAB Pathology Molecular Diagnostics lab, and Director of the UAB GBS Genetics, Genomics, and Bioinformatics PhD theme.<\/p>\n

She received her PhD in Genetics at the Imperial College London in the UK and completed her postdoctoral training at the Seattle Biomedical Research Institute in Seattle, Washington.
\nHer research interests include the development and application of omic, computational biology, bioinformatic, and data science-based methods to identify and understand the impact of causal molecular variation in patients with a variety of undiagnosed, misdiagnosed, or non-definitively molecularly diagnosed diseases. These studies span rare diseases and common diseases including cancer. Her lab also focuses on the identification and study of modifier and pharmacogenomics associated variation that alters an individual’s response to therapeutics or modifies clinical presentation, progression, and\/or outcome.<\/p>\n

For more information, contact:<\/strong>
\nThomas May
\nMedical Ethics Program Director
\nthomas.may@wsu.edu<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Ethics, Informatics, and Artificial Intelligence in Medical Practice November 9 Noon – 1:00 p.m. Bioethics Grand Rounds are sponsored by the Elson S. Floyd College of Medicine Certificate Program in […]<\/p>\n","protected":false},"author":26507,"featured_media":25153,"comment_status":"open","ping_status":"closed","template":"","meta":{"_tribe_events_status":"","_tribe_events_status_reason":""},"tags":[],"tribe_events_cat":[77],"wsuwp_university_location":[],"wsuwp_university_org":[],"event_city":"","event_state":"","event_venue":"","event_organizer":"Thomas May","event_organizer_email":"thomas.may@wsu.edu","event_organizer_phone":"","event_organizer_website":"","event_website":"","event_cost":"","event_excerpt":"Ethics, Informatics, and Artificial Intelligence in Medical Practice\nNovember 9\nNoon – 1:00 p.m.\nBioethics Grand Rounds are sponsored by the Elson S. Floyd College of Medicine Certificate Program in Medical Ethics, offered in collaboration with the Kaiser Permanente Northern California Regional Ethics program.\nRegister\nAbout the speakers:\nYoav Schlesinger is an Architect of Ethical AI Practice in the Office of Ethical and Humane Use of Technology at Salesforce, where he helps the company embed and instantiate ethical production practices to maximize the societal benefits of AI. Prior to coming to Salesforce, Yoav was a founding member of the Tech and Society Solutions Lab at Omidyar Network, where he led the Responsible Computer Science Challenge and helped develop Ethical OS, a risk mitigation toolkit for product managers. Before that, he had a career as a leader and two-time founder of mission-driven, nonprofit organizations. He graduated from Stanford University with degrees in Religious Studies and Political Science and Honors in International Security Studies.\nElizabeth Worthey, PhD, is an Endowed Associate Professor at the University of Alabama, Birmingham and the Director of the UAB School of Medicine Center for Computational Genomics and Data Science. She is also an Associate Director for the Hugh Kaul Precision Medicine Institute, Director of Bioinformatics for the O\u2019Neal Comprehensive Cancer Center, Director of Bioinformatics for the UAB Pathology Molecular Diagnostics lab, and Director of the UAB GBS Genetics, Genomics, and Bioinformatics PhD theme.\nShe received her PhD in Genetics at the Imperial College London in the UK and completed her postdoctoral training at the Seattle Biomedical Research Institute in Seattle, Washington.\nHer research interests include the development and application of omic, computational biology, bioinformatic, and data science-based methods to identify and understand the impact of causal molecular variation in patients with a variety of undiagnosed, misdiagnosed, or non-definitively molecularly diagnosed diseases. These studies span rare diseases and common diseases including cancer. Her lab also focuses on the identification and study of modifier and pharmacogenomics associated variation that alters an individual’s response to therapeutics or modifies clinical presentation, progression, and\/or outcome.\nFor more information, contact:\nThomas May\nMedical Ethics Program Director\nthomas.may@wsu.edu","start_date":"2022-11-09 12:00:00","end_date":"2022-11-09 13:00:00","_links":{"self":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/25147"}],"collection":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/users\/26507"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/comments?post=25147"}],"version-history":[{"count":10,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/25147\/revisions"}],"predecessor-version":[{"id":25447,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/25147\/revisions\/25447"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/media\/25153"}],"wp:attachment":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/media?parent=25147"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/tags?post=25147"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/tribe_events_cat?post=25147"},{"taxonomy":"wsuwp_university_location","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/wsuwp_university_location?post=25147"},{"taxonomy":"wsuwp_university_org","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/wsuwp_university_org?post=25147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}